Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 receptor PET imaging add-on in Ver-A-T1D
2020-004966-20Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Verapamil arm with Placebo arm (2 arms). Primary endpoint: Pancreatic 68Ga-NODAGA-exendin uptake (baseline and 12 months). Started May 2021; status: completed.
02
Drugs
verapamil
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2020-004966-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004966-20.